Literature DB >> 24738141

Comparison of three reference methods for the measurement of intracellular pH using 31P MRS in healthy volunteers and patients with lymphoma.

Mihaela Rata, Sharon L Giles, Nandita M deSouza, Martin O Leach, Geoffrey S Payne.   

Abstract

31P magnetic resonance spectroscopy (31P MRS) can measure intracellular pH (pHi) using the chemical shift difference between pH-dependent inorganic phosphate (Pi) and a pH-independent reference peak. This study compared three different frequency reference peaks [phosphocreatine (PCr), α resonance of adenosine triphosphate (αATP) and water (using 1H MRS)] in a cohort of 10 volunteers and eight patients with non-Hodgkin's lymphoma (NHL). Well-resolved chemical shift imaging (CSI) spectra were acquired on a 1.5T scanner for muscle, liver and tumour. The pH was calculated for all volunteers and patients using the available methods. The consistency of the resulting pH was evaluated. The direct Pi–PCr method was best for those spectra with a very well-defined PCr, such as muscle (pH=7.05 ± 0.02). In liver, the Pi–αATP method gave more consistent results (pH=7.30 ± 0.06) than the calibrated water-based method (pH=7.27 ± 0.11). In NHL nodes, the measured pH using the Pi–αATP method was 7.25 ± 0.12. Given that the measured range includes some biological variation in individual patients, treatment-related changes of the order of 0.1 pH units should be detectable. 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24738141      PMCID: PMC4290015          DOI: 10.1002/nbm.3047

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


α resonance of adenosine triphosphate chemical shift imaging JAVA‐based magnetic resonance user interface non‐Hodgkin's lymphoma intracellular pH phosphocreatine inorganic phosphate standard deviation

INTRODUCTION

Most tumours, contrary to expectation, exhibit slightly alkaline values of intracellular pH (pHi) 1, which have been associated with a favourable environment for tumour growth 2. Inhibition of tumour growth may occur with anticancer agents that acidify the intracellular tumour environment, such as inhibitors of the monocarboxylate transporter 3 that blocks the membrane transport of the final products of glycolysis. In these instances, the measurement of drug‐induced pHi changes offers the opportunity to verify the mechanism of drug action. Measurement of pHi using 31P MRS was first proposed about 30 years ago 4. The initial human applications included muscle exercise studies 5, 6 and the detection of some muscle pathologies, such as the glycogen storage disease McArdle's syndrome 7. The measurement of pH by 31P MRS 4, 8 relies on the chemical shift difference between pH‐dependent inorganic phosphate (Pi) and a pH‐independent reference peak. In vivo 31P MRS has the advantage of being a noninvasive and nonperturbing technique, enabling longitudinal clinical studies to be performed through a course of treatment. Three internal frequency references have been suggested to measure pHi: two 31P‐derived peaks and a 1H‐derived peak. The phosphocreatine (PCr) peak is widely used for pH measurement in muscle 9, 10, 11 as a result of its strong nonoverlapping single resonance, but, in other tissues, as well as in tumours, it may be less suitable owing to its low concentration. One alternative is to use the α resonance of adenosine triphosphate (αATP) 12, 13, as this compound is visible in most spectra and is relatively insensitive to pH and ion content 4. A third method is based on the 1H MRS signal from tissue water acquired from the same region 14, whose resonance frequency is scaled to create a ‘virtual reference’ peak in the 31P spectrum. Although this method requires a dual‐receiver coil, the water resonance is a well‐defined single peak with a very good signal‐to‐noise ratio. In addition, technology has improved since the initial evaluation of the method, permitting simplification of the measurement protocol, particularly with regard to digital resolution of the frequency synthesiser, while modern shielded gradients substantially reduce the field shift from eddy currents. These methods have all been available for some time. However, given the recent interest in exploring the use of pHi as a biomarker of some new targeted anticancer therapies, it is timely to compare the three methods on modern hardware, and to obtain estimates of their precision. In this study, we calibrated the water reference method in human calf (gastrocnemius) muscle, compared with PCr, αATP and the water reference in muscle and liver (in volunteers), and applied the best method to obtain a measurement of pH in a pilot cohort of patients with non‐Hodgkin's lymphoma (NHL). Several other 31P MRS methods of measuring pH based on chemical shifts among the ATP peaks 15 or between βATP and PCr peaks 16 are available. In addition to pH value measurement, some of these methods can simultaneously estimate intracellular [Mg2+] concentration. Such complex equations, however, require further calibrations to determine unknown constants for each study design. In the present study, we focused on comparing the most established pH‐dependent peak (Pi) with three options for the reference peak.

EXPERIMENTAL

Volunteers and patients

Data were obtained from 10 healthy volunteers, aged 24–58 years (five right gastrocnemius muscle and five liver spectra), and eight newly diagnosed patients with NHL, aged 38–79 years (three abdomen, three chest, one neck and one knee spectra). The NHL subtypes were; four diffuse large B‐cell lymphomas, two follicular lymphomas and two mixed lymphomas (diffuse large B‐cell lymphoma + follicular lymphoma). All volunteers and patients gave written informed consent and the scanning protocol was approved by the local ethical committee. Only patients with superficial and/or bulky tumour mass (>2 × 2 × 2 cm3 on prior computed tomography scan) were included in the study.

MR examination

All data were acquired using a 1.5 T Avanto scanner (Siemens, Erlangen, Germany) using three custom‐built dual 1H/31P surface coils 17, 18, 19 of 5, 8 and 12 cm in diameter. In the volunteer measurements, the 8 cm coil was chosen for the superficial calf muscle examination, whereas the 12 cm coil offered better coverage of the whole liver. For each patient, the appropriate surface coil was chosen individually, based on tumour size and location. Attention was paid to position the acquisition voxel within viable tumour tissue, excluding large blood vessels, necrotic or cystic regions. The MR protocol consisted of: a) three orthogonal anatomical images for planning the spectral acquisition; b) 1H single voxel spectroscopy; and c) 3D 1H‐decoupled 31P chemical shift imaging (CSI). The anatomical images were based on a T 2 steady‐state gradient echo sequence with the following parameters: field of view, 400 mm; TR/TE = 3.79/1.9 ms; 12 slices with a thickness of 7 mm. A water spectrum was acquired using a 1H MRS point‐resolved spectroscopy sequence (with TR/TE = 2000/135 ms; vector size, 1024; bandwidth, 1000 Hz; 60 averages; total acquisition time, ~2 min). The transmit frequency of the 1H MRS acquisition was centred to the water frequency following the standard procedure of the scanner software. The 31P CSI protocol (TR = 1000 ms; RF pulse calibrated to 45° at the voxel centre; vector size, 1024; 8 × 8 × 8 phase‐encoding steps; two averages; spectral width, 2000 Hz; full k‐space coverage with 100% Hamming filter; total acquisition time, ~17 min) acquired information from the same voxel as for the water spectrum. The Hamming filter was applied in scanner software to smooth the truncation effect caused by the limited coverage of k space (eight steps). The 31P transmit frequency was set in two steps. Firstly, the frequency was calibrated using a 31P reference sample (triphenyl phosphate) sited within the 31P coil housing. Secondly, the scanner frequency was offset from this reference frequency by a known value (–3563 Hz) to centre the spectrum relative to the metabolites (centre frequency between γATP and αATP). All volunteer spectra (muscle or liver) were derived from a 27 mL isotropic voxel. The patient voxel size varied from 15.6 to 125 mL depending on the tumour volume. The same shimming was used for both 1H and 31P acquisitions. No water spectra were acquired in the patient cohort. To test for frequency shifts from eddy current effects, localised and unlocalised phantom data were acquired for both 1H and 31P MRS using the 5 cm 1H/31P coil. Two spherical phantoms of 3 cm in diameter were used. The 1H phantom contained a 0.13 mM MnCl2 water solution, and the 31P phantom contained 0.1 M NaH2PO4 doped with 0.24 mM NiCl2. Both phantoms were positioned slightly off‐isocentre (~10 cm laterally) similar to most in vivo locations. As phantom data were expected to have a good signal‐to‐noise ratio and not to suffer from any motion, the number of averages used for in vivo acquisitions could be reduced. The phantom data were hence acquired with 10 averages for the 1H single‐voxel spectroscopy and one average for 31P CSI.

Post‐processing and pH measurement

Spectra were processed using the JAVA‐based magnetic resonance user interface (jMRUI) v.5 software and quantified using a nonlinear least‐squares algorithm [AMARES 20]. pH values were calculated using three reference peak methods for the volunteer data and two for the patient data. The pH calculation used the following calibrated form of the Henderson–Hasselbalch equation 11, 13: where δ is the chemical shift frequency difference between pH‐dependent Pi and a pH‐independent reference peak, measured in parts per million (ppm). Method 1 (PCr based) used the chemical shift difference δ between Pi and PCr: Method 2 (αATP based) used the same equation, but with δ calculated from the chemical shift of αATP: where 7.56 ppm represents the expected frequency of the centre of the αATP doublet peak relative to PCr. Method 3 [water‐derived PCr reference, a simplified method of Madden et al. 14] used the water signal from the 1H spectrum, acquired from the same voxel as for 31P MRS, to estimate the frequency of the PCr peak in the 31P spectrum (see Fig. 1):
Figure 1

Example of 1H and 31P MR spectra acquired at 1.5 T in a healthy volunteer muscle used to calibrate the water‐based method. H2O, water; PCr, phosphocreatine; Pi, inorganic phosphate; α, β, γ, nucleoside triphosphates. Peaks of interest of each spectrum are labelled in green. For this particular example, the measured frequencies were = 63.641294 MHz and f PCr = 25.762264 MHz, giving k = 0.40480421. The frequency of water signal from the 1H spectrum was multiplied by the experimentally derived constant k to create a virtual peak in the 31P spectrum, called the estimated PCr. Subsequently, pH was calculated using the Henderson–Hasselbalch equation and the chemical shift difference between the measured Pi and the estimated PCr.

Example of 1H and 31P MR spectra acquired at 1.5 T in a healthy volunteer muscle used to calibrate the water‐based method. H2O, water; PCr, phosphocreatine; Pi, inorganic phosphate; α, β, γ, nucleoside triphosphates. Peaks of interest of each spectrum are labelled in green. For this particular example, the measured frequencies were = 63.641294 MHz and f PCr = 25.762264 MHz, giving k = 0.40480421. The frequency of water signal from the 1H spectrum was multiplied by the experimentally derived constant k to create a virtual peak in the 31P spectrum, called the estimated PCr. Subsequently, pH was calculated using the Henderson–Hasselbalch equation and the chemical shift difference between the measured Pi and the estimated PCr. This method relies on the fact that the absolute frequency positions (in Hz) of both water and PCr are proportional to the local magnetic field B local, which is the main magnetic field B 0 affected by any local susceptibility effects. The absolute frequency of PCr is then defined as: where is the 31P gyromagnetic ratio and σ PCr is the chemical shielding effect for PCr. The absolute frequency of water is similarly defined and, by dividing the two equations, we obtain: Thus, once one has measured or calculated k, one can use the previous relation to estimate the PCr frequency from the water frequency. In the previous work of Madden et al. 14, it was necessary to include corrections for limited frequency resolution of the synthesiser, and for frequency shifts caused by eddy currents. These should not be required with modern hardware, but localised pulse‐acquire spectra were acquired in a test object to check that there was no frequency shift from eddy current effects. The multiplication factor k was calibrated experimentally in in vivo muscle datasets exhibiting high PCr, and then applied in liver spectra. The same equation as for Method 1 was subsequently applied.

RESULTS AND DISCUSSION

1H phantom and 31P phantom data were acquired in both localised and unlocalised spectra. The 1H MRS measured a water peak at the same frequency (0 Hz) for both types of acquisition. Similarly, a 31P signal was acquired at the same position (131.83 Hz) for localised versus unlocalised spectra. The sampling interval was 1 Hz for all 1H and 31P experiments. These results suggest that, if present, effects from eddy currents were smaller than 1 Hz. Therefore, no eddy current corrections were applied to further acquisitions. Well‐resolved spectra were acquired from healthy volunteers and patients with NHL despite the relatively deep position of some voxels (depth range, 4–8 cm from the coil). Figure 2 illustrates example fitted spectra for each type of data acquisition. Small, but measurable, PCr peaks were observed in liver and tumour spectra. The lack of motion gating, however, meant that contamination from intense PCr signals of superficial muscle may have contributed to these peaks.
Figure 2

Example 31P MR spectra acquired at 1.5 T for muscle, liver and non‐Hodgkin's lymphoma (NHL). PCr, phosphocreatine; PDE, phosphodiesters; Pi, inorganic phosphate; PME, phosphomonoesters; α, β, γ, nucleoside triphosphates. Peaks of interest are labelled in green.

Example 31P MR spectra acquired at 1.5 T for muscle, liver and non‐Hodgkin's lymphoma (NHL). PCr, phosphocreatine; PDE, phosphodiesters; Pi, inorganic phosphate; PME, phosphomonoesters; α, β, γ, nucleoside triphosphates. Peaks of interest are labelled in green. In muscle, the average value of the constant k between the 31P MRS frequency of PCr and the 1H MRS frequency of water was 0.404804239 ± 0.000000015. The mean measured position of the water reference in the 31P spectra was 0.0004 ± 0.0367 ppm. pH values in the three tissues using the different methods are shown in Table 1. pH measurements in muscle were the most consistent, probably owing to the well‐defined PCr peak and absence of tissue motion, with Method 1 (Pi–PCr) exhibiting a minimal standard deviation (SD) (0.02 pH units). In liver, the PCr peak was less clearly detected and may have arisen from muscle outside the selected voxel; the αATP and water reference methods were most consistent, with the Pi–αATP method giving the smallest variation of 0.06 pH units.
Table 1

Intracellular pH measurements (mean ± SD) in healthy volunteers and patients with non‐Hodgkin's lymphoma (NHL) using three different methods

PCr basedαATP basedWater based
pH measurementMeanSDMeanSDMeanSD
Volunteer: muscle7.050.027.000.037.030.04
Volunteer: liver7.210.127.300.067.270.11
Patient: NHL7.170.177.250.12nana

na, not applicable.

Intracellular pH measurements (mean ± SD) in healthy volunteers and patients with non‐Hodgkin's lymphoma (NHL) using three different methods na, not applicable. This study analysed data from volunteers and patients in a sequential manner. Observations derived from the analysis of volunteer data generated slight modification of the acquisition protocol for the patient cohort. All three methods of measurement of pH presented here were tested on volunteers (muscle and liver tissue), but only two were further applied to tumours in patients. The water‐derived method failed to demonstrate improvement in accuracy of measurement for both muscle and liver data. Therefore, in order to avoid extra acquisition with no expected benefit, no water acquisition was performed for the patient cohort. In tumour (NHL), the Pi–αATP method yielded a slightly alkaline pH of 7.25 with a much smaller SD (0.12) than using the PCr method (0.17). Among the three types of tissue investigated here, the greatest variation in the measurement of pH was in tumours, but, even here, the variation was relatively low (0.12 pH units). Given the biological variation of tumours, these results are encouraging and should result in a good intra‐patient repeatability. The performance of the water reference method in liver was disappointing, given the good signal‐to‐noise ratio and well‐defined single resonance of the water peak. Although the use of two separate measurements tends to increase uncertainty, the consistent result in muscle (SD = 0.04 ppm) shows that intrinsically the method is working well. Factors such as digital resolution, amplifier frequency linearity between 31P and 1H, and arithmetic precision of the analysis were the same for muscle and liver measurements. However, in liver, the slightly larger water linewidths (12.6 Hz in liver, compared with 10.7 Hz in muscle) and the presence of motion may have affected the result. The conclusion of this study used direct comparison of the SD values for each method and tissue. A statistical analysis of variance, such as F‐test (two pH methods) and Bartlett test (three pH methods), was performed. The results may be regarded with caution because of the small sample size (five and eight data points). The reported p values (at a significance level of 95%) were 0.31 (muscle), 0.5 (liver) and 0.35 (tumour). These statistical tests show no significant difference between the measured SD values of the different methods. However, although the statistical analysis does not support a preferred method, two further considerations influence a recommendation. The water method (with its extended acquisition time) showed no benefit for the quality of pH measurement. The PCr–Pi method could result in the PCr peak visible in liver/tumour spectra being contaminated from adjacent muscle tissue, making this method less reliable. For these reasons, we recommend the use of the αATP method for liver and tumour acquisitions. It is generally acknowledged that the Pi peak has both intra‐ and extracellular components. In this study, only one single Pi peak of the MR spectrum was resolved, implying that the measured pH was a weighted average of intracellular and extracellular pH. However, the contributions from pHi are expected to be at least 85% of the total pH 1. Such a contribution of the intracellular volume to the measured pH can be estimated when the total tumour volume and the fractional volume of extracellular water are known 21. Calculations show that, if the extracellular volume does not exceed 55%, then pH measured by 31P MRS largely represents pHi 22. This extracellular compartment is expected to be larger in tumour tissue than in normal tissue owing to necrotic or cystic regions. The extracellular contamination was minimised here by careful positioning of the voxel of interest to avoid such regions. Overall repeatability, will be influenced by a combination of factors, e.g. voxel repositioning uncertainty, coil sensitivity, shimming quality, subject motion and random noise. To detect drug response in the context of measurement variability, repeatability acquisitions are desirable in any longitudinal trial. The noninvasive nature of the examination and the lack of need for an extrinsic contrast agent make this easier to implement. The 31P MRS method (including images and calibrations), however, requires a total scanning time of about 40 min per visit and its application is limited to superficial tumours of about 2–3 cm in size, or to larger tumours if deeper, for signal detection using a surface coil. In conclusion, pH was successfully calculated for all volunteers and patients. The direct Pi–PCr method is best only for spectra with very well‐defined PCr, such as muscle. The Pi–αATP method measured pH in liver with an SD value of 0.06 units, and in tumours with an SD value of 0.12 pH units, and is preferred in these tissues.
  20 in total

Review 1.  Causes and consequences of tumour acidity and implications for treatment.

Authors:  M Stubbs; P M McSheehy; J R Griffiths; C L Bashford
Journal:  Mol Med Today       Date:  2000-01

2.  Measurement of human skeletal muscle oxidative capacity by 31P-MR spectroscopy: a cross-validation with in vitro measurements.

Authors:  Ian R Lanza; Sumit Bhagra; K Sreekumaran Nair; John D Port
Journal:  J Magn Reson Imaging       Date:  2011-11       Impact factor: 4.813

3.  Determination of intracellular pH by 31P magnetic resonance.

Authors:  R B Moon; J H Richards
Journal:  J Biol Chem       Date:  1973-10-25       Impact factor: 5.157

4.  Examination of a case of suspected McArdle's syndrome by 31P nuclear magnetic resonance.

Authors:  B D Ross; G K Radda; D G Gadian; G Rocker; M Esiri; J Falconer-Smith
Journal:  N Engl J Med       Date:  1981-05-28       Impact factor: 91.245

5.  Radio-frequency probe for 1H decoupled 31P MRS of the head and neck region.

Authors:  D W Klomp; D J Collins; H J van den Boogert; A Schwarz; M Rijpkema; T Prock; G S Payne; M O Leach; A Heerschap
Journal:  Magn Reson Imaging       Date:  2001-06       Impact factor: 2.546

6.  High-energy phosphate metabolism during incremental calf exercise in patients with unilaterally symptomatic peripheral arterial disease measured by phosphor 31 magnetic resonance spectroscopy.

Authors:  Andreas Greiner; Regina Esterhammer; Hubert Messner; Mathias Biebl; Hannes Mühlthaler; Gustav Fraedrich; Werner R Jaschke; Michael F H Schocke
Journal:  J Vasc Surg       Date:  2006-05       Impact factor: 4.268

7.  31P-NMR investigation of solid tumours in the living rat.

Authors:  J R Griffiths; A N Stevens; R A Iles; R E Gordon; D Shaw
Journal:  Biosci Rep       Date:  1981-04       Impact factor: 3.840

8.  Measurements of in vivo 31P nuclear magnetic resonance spectra in neuroectodermal tumors for the evaluation of the effects of chemotherapy.

Authors:  S Naruse; K Hirakawa; Y Horikawa; C Tanaka; T Higuchi; S Ueda; H Nishikawa; H Watari
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

9.  Tumor metabolism: cancer cells give and take lactate.

Authors:  Gregg L Semenza
Journal:  J Clin Invest       Date:  2008-11-20       Impact factor: 14.808

10.  Comparison of three reference methods for the measurement of intracellular pH using 31P MRS in healthy volunteers and patients with lymphoma.

Authors:  Mihaela Rata; Sharon L Giles; Nandita M deSouza; Martin O Leach; Geoffrey S Payne
Journal:  NMR Biomed       Date:  2014-02       Impact factor: 4.044

View more
  11 in total

Review 1.  Assessing tissue metabolism by phosphorous-31 magnetic resonance spectroscopy and imaging: a methodology review.

Authors:  Yuchi Liu; Yuning Gu; Xin Yu
Journal:  Quant Imaging Med Surg       Date:  2017-12

Review 2.  Translating preclinical MRI methods to clinical oncology.

Authors:  David A Hormuth; Anna G Sorace; John Virostko; Richard G Abramson; Zaver M Bhujwalla; Pedro Enriquez-Navas; Robert Gillies; John D Hazle; Ralph P Mason; C Chad Quarles; Jared A Weis; Jennifer G Whisenant; Junzhong Xu; Thomas E Yankeelov
Journal:  J Magn Reson Imaging       Date:  2019-03-29       Impact factor: 4.813

Review 3.  Imaging: seeing muscle in new ways.

Authors:  Adam Schiffenbauer
Journal:  Curr Opin Rheumatol       Date:  2014-11       Impact factor: 5.006

4.  Simultaneous Assessment of Intracellular and Extracellular pH Using Hyperpolarized [1-13C]Alanine Ethyl Ester.

Authors:  Jun Chen; Edward P Hackett; Jaspal Singh; Zoltán Kovács; Jae Mo Park
Journal:  Anal Chem       Date:  2020-08-14       Impact factor: 6.986

5.  Mapping pH at Cancer Cell Surfaces.

Authors:  Da Wei; Donald M Engelman; Yana K Reshetnyak; Oleg A Andreev
Journal:  Mol Imaging Biol       Date:  2019-12       Impact factor: 3.484

6.  Magnetic resonance imaging and spectroscopy for differential assessment of liver abnormalities induced by Opisthorchis felineus in an animal model.

Authors:  Alexandra G Pershina; Vladimir V Ivanov; Lina V Efimova; Oleg B Shevelev; Sergey V Vtorushin; Tatjana V Perevozchikova; Alexey E Sazonov; Ludmila M Ogorodova
Journal:  PLoS Negl Trop Dis       Date:  2017-07-14

Review 7.  Integrating Quantitative Assays with Biologically Based Mathematical Modeling for Predictive Oncology.

Authors:  Anum S Kazerouni; Manasa Gadde; Andrea Gardner; David A Hormuth; Angela M Jarrett; Kaitlyn E Johnson; Ernesto A B F Lima; Guillermo Lorenzo; Caleb Phillips; Amy Brock; Thomas E Yankeelov
Journal:  iScience       Date:  2020-11-13

8.  MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance Spectroscopy.

Authors:  Mounia Beloueche-Babari; Slawomir Wantuch; Teresa Casals Galobart; Markella Koniordou; Harold G Parkes; Vaitha Arunan; Yuen-Li Chung; Thomas R Eykyn; Paul D Smith; Martin O Leach
Journal:  Cancer Res       Date:  2017-09-18       Impact factor: 12.701

9.  In Vitro 31P MR Chemical Shifts of In Vivo-Detectable Metabolites at 3T as a Basis Set for a Pilot Evaluation of Skeletal Muscle and Liver 31P Spectra with LCModel Software.

Authors:  Petr Sedivy; Tereza Dusilova; Milan Hajek; Martin Burian; Martin Krššák; Monika Dezortova
Journal:  Molecules       Date:  2021-12-14       Impact factor: 4.411

10.  Comparison of three reference methods for the measurement of intracellular pH using 31P MRS in healthy volunteers and patients with lymphoma.

Authors:  Mihaela Rata; Sharon L Giles; Nandita M deSouza; Martin O Leach; Geoffrey S Payne
Journal:  NMR Biomed       Date:  2014-02       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.